Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

Similar articles for PubMed (Select 19783848)

1.

P2Y12 receptor protein in cortical gray matter lesions in multiple sclerosis.

Amadio S, Montilli C, Magliozzi R, Bernardi G, Reynolds R, Volonté C.

Cereb Cortex. 2010 Jun;20(6):1263-73. doi: 10.1093/cercor/bhp193. Epub 2009 Sep 26.

2.

Elevated activity and microglial expression of myeloperoxidase in demyelinated cerebral cortex in multiple sclerosis.

Gray E, Thomas TL, Betmouni S, Scolding N, Love S.

Brain Pathol. 2008 Jan;18(1):86-95. Epub 2007 Nov 27.

PMID:
18042261
3.

Cortical remyelination: a new target for repair therapies in multiple sclerosis.

Chang A, Staugaitis SM, Dutta R, Batt CE, Easley KE, Chomyk AM, Yong VW, Fox RJ, Kidd GJ, Trapp BD.

Ann Neurol. 2012 Dec;72(6):918-26. doi: 10.1002/ana.23693. Epub 2012 Oct 17.

4.

Subpial demyelination in the cerebral cortex of multiple sclerosis patients.

Bø L, Vedeler CA, Nyland HI, Trapp BD, Mørk SJ.

J Neuropathol Exp Neurol. 2003 Jul;62(7):723-32.

PMID:
12901699
5.

An animal model of cortical and callosal pathology in multiple sclerosis.

Mangiardi M, Crawford DK, Xia X, Du S, Simon-Freeman R, Voskuhl RR, Tiwari-Woodruff SK.

Brain Pathol. 2011 May;21(3):263-78. doi: 10.1111/j.1750-3639.2010.00444.x. Epub 2010 Nov 10.

PMID:
21029240
6.

High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis.

Schmierer K, Parkes HG, So PW, An SF, Brandner S, Ordidge RJ, Yousry TA, Miller DH.

Brain. 2010 Mar;133(Pt 3):858-67. doi: 10.1093/brain/awp335. Epub 2010 Jan 31.

7.

Cuprizone-induced demyelination in the rat cerebral cortex and thyroid hormone effects on cortical remyelination.

Silvestroff L, Bartucci S, Pasquini J, Franco P.

Exp Neurol. 2012 May;235(1):357-67. doi: 10.1016/j.expneurol.2012.02.018. Epub 2012 Mar 7.

PMID:
22421533
8.

Grey matter pathology in multiple sclerosis.

Bö L, Geurts JJ, Mörk SJ, van der Valk P.

Acta Neurol Scand Suppl. 2006;183:48-50. Review.

PMID:
16637929
9.

Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: correlation with microglia infiltration, demyelination, and neuronal and synaptic damage.

Vercellino M, Merola A, Piacentino C, Votta B, Capello E, Mancardi GL, Mutani R, Giordana MT, Cavalla P.

J Neuropathol Exp Neurol. 2007 Aug;66(8):732-9.

PMID:
17882017
10.

Cortical demyelination in PML and MS: Similarities and differences.

Moll NM, Rietsch AM, Ransohoff AJ, Cossoy MB, Huang D, Eichler FS, Trapp BD, Ransohoff RM.

Neurology. 2008 Jan 29;70(5):336-43.

PMID:
17914063
11.

Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis.

Bö L, Geurts JJ, van der Valk P, Polman C, Barkhof F.

Arch Neurol. 2007 Jan;64(1):76-80.

PMID:
17210812
12.

Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions.

Peterson JW, Bö L, Mörk S, Chang A, Trapp BD.

Ann Neurol. 2001 Sep;50(3):389-400.

PMID:
11558796
13.

Myelin debris regulates inflammatory responses in an experimental demyelination animal model and multiple sclerosis lesions.

Clarner T, Diederichs F, Berger K, Denecke B, Gan L, van der Valk P, Beyer C, Amor S, Kipp M.

Glia. 2012 Oct;60(10):1468-80. doi: 10.1002/glia.22367. Epub 2012 Jun 11.

PMID:
22689449
14.

Widespread demyelination in the cerebellar cortex in multiple sclerosis.

Kutzelnigg A, Faber-Rod JC, Bauer J, Lucchinetti CF, Sorensen PS, Laursen H, Stadelmann C, Brück W, Rauschka H, Schmidbauer M, Lassmann H.

Brain Pathol. 2007 Jan;17(1):38-44.

PMID:
17493036
15.

Cortical demyelination and diffuse white matter injury in multiple sclerosis.

Kutzelnigg A, Lucchinetti CF, Stadelmann C, Brück W, Rauschka H, Bergmann M, Schmidbauer M, Parisi JE, Lassmann H.

Brain. 2005 Nov;128(Pt 11):2705-12. Epub 2005 Oct 17.

16.

Cellular distribution of glucose and monocarboxylate transporters in human brain white matter and multiple sclerosis lesions.

Nijland PG, Michailidou I, Witte ME, Mizee MR, van der Pol SM, van Het Hof B, Reijerkerk A, Pellerin L, van der Valk P, de Vries HE, van Horssen J.

Glia. 2014 Jul;62(7):1125-41. doi: 10.1002/glia.22667. Epub 2014 Apr 1.

PMID:
24692237
17.

Increased expression of distinct galectins in multiple sclerosis lesions.

Stancic M, van Horssen J, Thijssen VL, Gabius HJ, van der Valk P, Hoekstra D, Baron W.

Neuropathol Appl Neurobiol. 2011 Oct;37(6):654-71. doi: 10.1111/j.1365-2990.2011.01184.x.

PMID:
21501208
18.

The blood-brain barrier in cortical multiple sclerosis lesions.

van Horssen J, Brink BP, de Vries HE, van der Valk P, Bø L.

J Neuropathol Exp Neurol. 2007 Apr;66(4):321-8.

PMID:
17413323
19.

Distribution of the immune inhibitory molecules CD200 and CD200R in the normal central nervous system and multiple sclerosis lesions suggests neuron-glia and glia-glia interactions.

Koning N, Swaab DF, Hoek RM, Huitinga I.

J Neuropathol Exp Neurol. 2009 Feb;68(2):159-67. doi: 10.1097/NEN.0b013e3181964113. Erratum in: J Neuropathol Exp Neurol. 2009 May;68(5):594.

PMID:
19151626
20.

The histopathology of grey matter demyelination in multiple sclerosis.

Bø L.

Acta Neurol Scand Suppl. 2009;(189):51-7. doi: 10.1111/j.1600-0404.2009.01216.x. Review.

PMID:
19566500
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk